Phico Therapeutics secures £550,000 for Anti-Bacterial to target MRSASeptember 05, 2004Phico Therapeutics Ltd, a Cambridge-based company that has developed a unique anti-bacterial technology to treat the hospital superbug, MRSA, has raised £550,000 with the help of Oxfordshire Investment Opportunity Network (OION), Europe's leading technology business angel network. Phico's anti-bacterial technology, known as SASPject, is effective against all bacteria but can uniquely be targeted to destroy only harmful bacteria while leaving "good" skin and gut bacteria intact. The funding will enable Phico to take SASPject through to clinical trials. Dr Heather Fairhead, Chief Executive Officer of Phico Therapeutics, said: "Phico's anti-bacterial SASPject technology is effectively a lethal injection for bacteria. Uniquely, SASPject combines an anti-bacterial protein (SASP) with a delivery vector programmed to inject the SASP protein directly into selected bacteria, so it wipes out only harmful bacteria. It is expected to have far fewer side effects than conventional antibiotics. SASPject can de-activate or 'turn off' bacterial DNA, putting bacteria into a state of suspended animation and halting the spread of infection, giving the immune system time to eliminate the bacteria. It is extremely effective against antibiotic resistant bacteria, such as the MRSA superbug, with SASPject turning off the genes that cause resistance to antibiotics. Conventional antibiotics cannot do this."
Dr Fairhead commented on how the investment will help Phico: "Phico has already demonstrated that SASPject works in the laboratory, and the funding raised through Oxfordshire Investment Opportunity Network will help to take us through to the start of human clinical trials in 2005, as the next step in the process of bringing our products to market. For this funding round, we used a number of investment networks around the country and found OION to be one of the most effective. The presentation was well-organised and OION's manager was very proactive, attracting investment from investors in Portsmouth as well as Oxford." Jon Cox, Manager of Oxfordshire Investment Opportunity Network, said: "Phico offered the OION investors a unique and very relevant technology that has already demonstrated results, backed by a knowledgeable and experienced management team. On this occasion, members from our sister network, Solent Investment Opportunity Network (SION), invested alongside the OION investors enabling Phico to secure the funds needed to commercialise their technology." Oxford Innovation | |||||||||||||||||||||
|
Related Bacteria Current Events and Bacteria News Articles NYU scientists discover dangerous new method for bacterial toxin transfer Scientists have discovered a new way for bacteria to transfer toxic genes to unrelated bacterial species, a finding that raises the unsettling possibility that bacterial swapping of toxins and other disease-aiding factors may be more common than previously imagined. Evolution in action: Our antibodies take 'evolutionary leaps' to fight microbes With cold and flu season in full swing, the fact that viruses and bacteria rapidly evolve is apparent with every sneeze, sniffle, and cough. A new report in the January 2009 issue of The FASEB Journal, explains for the first time how humans keep up with microbes by rearranging the genes that make antibodies to foreign invaders. This research fills a significant gap in our understanding of how the immune system helps us survive. Understanding Extinct Microbes May Influence the State of Modern Human Health The study of ancient microbes may not seem consequential, but such pioneering research at the University of Oklahoma has implications for the state of modern human health. Cecil Lewis, assistant professor in the Department of Anthropology, says results of this research raise questions about the microbes living on and within people. Fewer deaths with preventive antibiotic use Administering antibiotics as a preventive measure to patients in intensive care units (ICUs) increases their chances of survival. This has emerged from a study involving nearly sixthousand Dutch patients in thirteen hospitals. Uncultured bacteria found in amniotic fluids of women who experience preterm births Researchers from Case Western Reserve University and Yale University have made a significant advancement in understanding the cause behind why some pregnant women suffer from inflammations in the inner womb without any signs of an infection. Viruses, start your engines! Peering at structures only atoms across, researchers have identified the clockwork that drives a powerful virus nanomotor. Because of the motor's strength--to scale, twice that of an automobile--the new findings could inspire engineers designing sophisticated nanomachines. Research team reports how, when life on Earth became so big In 3.5 billion years, life on earth went from single microscopic cells to giant sequoias and blue whales. Scientists have now documented quantitatively that the increase in maximum size of organisms was not gradual, but happened in two distinct bursts "tied to the geological evolution of the planet," said Michal Kowalewski, professor of geosciences at Virginia Tech. Small molecule triggers bacterial community While bacterial cells tend to be rather solitary individuals, they are also known to form intricately structured communities called biofilms. New research lights up chronic bacterial infection inside bone A new report demonstrates how a sensitive imaging technique gives scientists the upper hand in seeking out bacteria in chronic infections. Peering inside the skull of a mouse to solve meningitis mystery NYU Langone Medical Center scientists and their collaborators at the Scripps Research Institute in La Jolla, Calif., have discovered an unexpected cause for the fatal seizures seen in mice with viral meningitis, an infection of the central nervous system, according to a study published in the journal Nature. More Bacteria Current Events and Bacteria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||